Gates Foundation’s Dr. Bertozzi talks about what’s to come for HIV

Stefano Bertozzi, director of HIV and TB programs at The Gates Foundation, talks about what's to come for HIV. The RV144 HIV vaccine trial results “really reinvigorated the whole area of searching for an HIV vaccine,” he says, adding, “we hope the next trial will have greater efficacy than we did in the partial efficacy we saw in Thailand.” Read the full interview here.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account